img

Global Pravastatin Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pravastatin Market Insights, Forecast to 2034

Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease.
Global Pravastatin market is expected to reach to US$ 582 million in 2024, with a positive growth of %, compared with US$ 547 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pravastatin industry is evaluated to reach US$ 835 million in 2029. The CAGR will be 6.2% during 2024 to 2029.
Globally, Pravastatin key manufacturers include Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals and Glenmark, etc. Bristol-Myers Squibb, TEVA, SANDOZ are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Pravastatin were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Pravastatin market and estimated to attract more attentions from industry insiders and investors.
Pravastatin can be divided into 10mg Tablet, 20mg Tablet, 40mg Tablet and 80mg Tablet, etc. 10mg Tablet is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Pravastatin is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Pravastatin industry development. In 2022, global % sales of Pravastatin went into Adults filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Pravastatin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Pravastatin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol-Myers Squibb
TEVA
SANDOZ
APOTEX
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Cipla Inc.
Lupin Pharmaceuticals
Glenmark
Mylan
Aurobindo Pharma
Accord Healthcare
Upsher-Smith Laboratories
Hisun
Jiangxi Boyaseehot Pharmaceutical
Shanghai Shyndec Pharmaceutical
Daiichi Sankyo
North China Pharmaceutical Group
Segment by Type
10mg Tablet
20mg Tablet
40mg Tablet
80mg Tablet

Segment by Application


Adults
Children

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Pravastatin plant distribution, commercial date of Pravastatin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Pravastatin introduction, etc. Pravastatin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Pravastatin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Pravastatin Product Introduction
1.2 Market by Type
1.2.1 Global Pravastatin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 10mg Tablet
1.2.3 20mg Tablet
1.2.4 40mg Tablet
1.2.5 80mg Tablet
1.3 Market by Application
1.3.1 Global Pravastatin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pravastatin Sales Estimates and Forecasts 2018-2029
2.2 Global Pravastatin Revenue by Region
2.2.1 Global Pravastatin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pravastatin Revenue by Region (2018-2024)
2.2.3 Global Pravastatin Revenue by Region (2024-2029)
2.2.4 Global Pravastatin Revenue Market Share by Region (2018-2029)
2.3 Global Pravastatin Sales Estimates and Forecasts 2018-2029
2.4 Global Pravastatin Sales by Region
2.4.1 Global Pravastatin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pravastatin Sales by Region (2018-2024)
2.4.3 Global Pravastatin Sales by Region (2024-2029)
2.4.4 Global Pravastatin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pravastatin Sales by Manufacturers
3.1.1 Global Pravastatin Sales by Manufacturers (2018-2024)
3.1.2 Global Pravastatin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pravastatin in 2022
3.2 Global Pravastatin Revenue by Manufacturers
3.2.1 Global Pravastatin Revenue by Manufacturers (2018-2024)
3.2.2 Global Pravastatin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pravastatin Revenue in 2022
3.3 Global Key Players of Pravastatin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Pravastatin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pravastatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pravastatin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pravastatin, Product Offered and Application
3.8 Global Key Manufacturers of Pravastatin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pravastatin Sales by Type
4.1.1 Global Pravastatin Historical Sales by Type (2018-2024)
4.1.2 Global Pravastatin Forecasted Sales by Type (2024-2029)
4.1.3 Global Pravastatin Sales Market Share by Type (2018-2029)
4.2 Global Pravastatin Revenue by Type
4.2.1 Global Pravastatin Historical Revenue by Type (2018-2024)
4.2.2 Global Pravastatin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pravastatin Revenue Market Share by Type (2018-2029)
4.3 Global Pravastatin Price by Type
4.3.1 Global Pravastatin Price by Type (2018-2024)
4.3.2 Global Pravastatin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pravastatin Sales by Application
5.1.1 Global Pravastatin Historical Sales by Application (2018-2024)
5.1.2 Global Pravastatin Forecasted Sales by Application (2024-2029)
5.1.3 Global Pravastatin Sales Market Share by Application (2018-2029)
5.2 Global Pravastatin Revenue by Application
5.2.1 Global Pravastatin Historical Revenue by Application (2018-2024)
5.2.2 Global Pravastatin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pravastatin Revenue Market Share by Application (2018-2029)
5.3 Global Pravastatin Price by Application
5.3.1 Global Pravastatin Price by Application (2018-2024)
5.3.2 Global Pravastatin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pravastatin Market Size by Type
6.1.1 US & Canada Pravastatin Sales by Type (2018-2029)
6.1.2 US & Canada Pravastatin Revenue by Type (2018-2029)
6.2 US & Canada Pravastatin Market Size by Application
6.2.1 US & Canada Pravastatin Sales by Application (2018-2029)
6.2.2 US & Canada Pravastatin Revenue by Application (2018-2029)
6.3 US & Canada Pravastatin Market Size by Country
6.3.1 US & Canada Pravastatin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pravastatin Sales by Country (2018-2029)
6.3.3 US & Canada Pravastatin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pravastatin Market Size by Type
7.1.1 Europe Pravastatin Sales by Type (2018-2029)
7.1.2 Europe Pravastatin Revenue by Type (2018-2029)
7.2 Europe Pravastatin Market Size by Application
7.2.1 Europe Pravastatin Sales by Application (2018-2029)
7.2.2 Europe Pravastatin Revenue by Application (2018-2029)
7.3 Europe Pravastatin Market Size by Country
7.3.1 Europe Pravastatin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pravastatin Sales by Country (2018-2029)
7.3.3 Europe Pravastatin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pravastatin Market Size
8.1.1 China Pravastatin Sales (2018-2029)
8.1.2 China Pravastatin Revenue (2018-2029)
8.2 China Pravastatin Market Size by Application
8.2.1 China Pravastatin Sales by Application (2018-2029)
8.2.2 China Pravastatin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pravastatin Market Size by Type
9.1.1 Asia Pravastatin Sales by Type (2018-2029)
9.1.2 Asia Pravastatin Revenue by Type (2018-2029)
9.2 Asia Pravastatin Market Size by Application
9.2.1 Asia Pravastatin Sales by Application (2018-2029)
9.2.2 Asia Pravastatin Revenue by Application (2018-2029)
9.3 Asia Pravastatin Sales by Region
9.3.1 Asia Pravastatin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pravastatin Revenue by Region (2018-2029)
9.3.3 Asia Pravastatin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pravastatin Market Size by Type
10.1.1 Middle East, Africa and Latin America Pravastatin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pravastatin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pravastatin Market Size by Application
10.2.1 Middle East, Africa and Latin America Pravastatin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pravastatin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pravastatin Sales by Country
10.3.1 Middle East, Africa and Latin America Pravastatin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pravastatin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pravastatin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Overview
11.1.3 Bristol-Myers Squibb Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bristol-Myers Squibb Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Myers Squibb Recent Developments
11.2 TEVA
11.2.1 TEVA Company Information
11.2.2 TEVA Overview
11.2.3 TEVA Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 TEVA Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 TEVA Recent Developments
11.3 SANDOZ
11.3.1 SANDOZ Company Information
11.3.2 SANDOZ Overview
11.3.3 SANDOZ Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 SANDOZ Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SANDOZ Recent Developments
11.4 APOTEX
11.4.1 APOTEX Company Information
11.4.2 APOTEX Overview
11.4.3 APOTEX Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 APOTEX Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 APOTEX Recent Developments
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Information
11.5.2 Dr. Reddy's Laboratories Overview
11.5.3 Dr. Reddy's Laboratories Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Dr. Reddy's Laboratories Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr. Reddy's Laboratories Recent Developments
11.6 Zydus Pharmaceuticals
11.6.1 Zydus Pharmaceuticals Company Information
11.6.2 Zydus Pharmaceuticals Overview
11.6.3 Zydus Pharmaceuticals Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Zydus Pharmaceuticals Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zydus Pharmaceuticals Recent Developments
11.7 Cipla Inc.
11.7.1 Cipla Inc. Company Information
11.7.2 Cipla Inc. Overview
11.7.3 Cipla Inc. Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Cipla Inc. Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Inc. Recent Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Information
11.8.2 Lupin Pharmaceuticals Overview
11.8.3 Lupin Pharmaceuticals Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Lupin Pharmaceuticals Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lupin Pharmaceuticals Recent Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Overview
11.9.3 Glenmark Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Glenmark Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Glenmark Recent Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Overview
11.10.3 Mylan Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Mylan Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Information
11.11.2 Aurobindo Pharma Overview
11.11.3 Aurobindo Pharma Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Aurobindo Pharma Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Aurobindo Pharma Recent Developments
11.12 Accord Healthcare
11.12.1 Accord Healthcare Company Information
11.12.2 Accord Healthcare Overview
11.12.3 Accord Healthcare Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Accord Healthcare Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Accord Healthcare Recent Developments
11.13 Upsher-Smith Laboratories
11.13.1 Upsher-Smith Laboratories Company Information
11.13.2 Upsher-Smith Laboratories Overview
11.13.3 Upsher-Smith Laboratories Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Upsher-Smith Laboratories Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Upsher-Smith Laboratories Recent Developments
11.14 Hisun
11.14.1 Hisun Company Information
11.14.2 Hisun Overview
11.14.3 Hisun Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Hisun Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Hisun Recent Developments
11.15 Jiangxi Boyaseehot Pharmaceutical
11.15.1 Jiangxi Boyaseehot Pharmaceutical Company Information
11.15.2 Jiangxi Boyaseehot Pharmaceutical Overview
11.15.3 Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Jiangxi Boyaseehot Pharmaceutical Recent Developments
11.16 Shanghai Shyndec Pharmaceutical
11.16.1 Shanghai Shyndec Pharmaceutical Company Information
11.16.2 Shanghai Shyndec Pharmaceutical Overview
11.16.3 Shanghai Shyndec Pharmaceutical Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Shanghai Shyndec Pharmaceutical Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Shanghai Shyndec Pharmaceutical Recent Developments
11.17 Daiichi Sankyo
11.17.1 Daiichi Sankyo Company Information
11.17.2 Daiichi Sankyo Overview
11.17.3 Daiichi Sankyo Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Daiichi Sankyo Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Daiichi Sankyo Recent Developments
11.18 North China Pharmaceutical Group
11.18.1 North China Pharmaceutical Group Company Information
11.18.2 North China Pharmaceutical Group Overview
11.18.3 North China Pharmaceutical Group Pravastatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 North China Pharmaceutical Group Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 North China Pharmaceutical Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pravastatin Industry Chain Analysis
12.2 Pravastatin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pravastatin Production Mode & Process
12.4 Pravastatin Sales and Marketing
12.4.1 Pravastatin Sales Channels
12.4.2 Pravastatin Distributors
12.5 Pravastatin Customers
13 Market Dynamics
13.1 Pravastatin Industry Trends
13.2 Pravastatin Market Drivers
13.3 Pravastatin Market Challenges
13.4 Pravastatin Market Restraints
14 Key Findings in The Global Pravastatin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pravastatin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 10mg Tablet
Table 3. Major Manufacturers of 20mg Tablet
Table 4. Major Manufacturers of 40mg Tablet
Table 5. Major Manufacturers of 80mg Tablet
Table 6. Global Pravastatin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Pravastatin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Pravastatin Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Pravastatin Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Pravastatin Revenue Market Share by Region (2018-2024)
Table 11. Global Pravastatin Revenue Market Share by Region (2024-2029)
Table 12. Global Pravastatin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Pravastatin Sales by Region (2018-2024) & (K Units)
Table 14. Global Pravastatin Sales by Region (2024-2029) & (K Units)
Table 15. Global Pravastatin Sales Market Share by Region (2018-2024)
Table 16. Global Pravastatin Sales Market Share by Region (2024-2029)
Table 17. Global Pravastatin Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Pravastatin Sales Share by Manufacturers (2018-2024)
Table 19. Global Pravastatin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Pravastatin Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Pravastatin, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Pravastatin Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Pravastatin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Pravastatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pravastatin as of 2022)
Table 25. Global Key Manufacturers of Pravastatin, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Pravastatin, Product Offered and Application
Table 27. Global Key Manufacturers of Pravastatin, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pravastatin Sales by Type (2018-2024) & (K Units)
Table 30. Global Pravastatin Sales by Type (2024-2029) & (K Units)
Table 31. Global Pravastatin Sales Share by Type (2018-2024)
Table 32. Global Pravastatin Sales Share by Type (2024-2029)
Table 33. Global Pravastatin Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Pravastatin Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Pravastatin Revenue Share by Type (2018-2024)
Table 36. Global Pravastatin Revenue Share by Type (2024-2029)
Table 37. Pravastatin Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Pravastatin Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Pravastatin Sales by Application (2018-2024) & (K Units)
Table 40. Global Pravastatin Sales by Application (2024-2029) & (K Units)
Table 41. Global Pravastatin Sales Share by Application (2018-2024)
Table 42. Global Pravastatin Sales Share by Application (2024-2029)
Table 43. Global Pravastatin Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Pravastatin Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Pravastatin Revenue Share by Application (2018-2024)
Table 46. Global Pravastatin Revenue Share by Application (2024-2029)
Table 47. Pravastatin Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Pravastatin Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Pravastatin Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Pravastatin Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Pravastatin Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Pravastatin Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Pravastatin Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Pravastatin Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Pravastatin Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Pravastatin Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Pravastatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Pravastatin Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Pravastatin Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Pravastatin Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Pravastatin Sales by Country (2024-2029) & (K Units)
Table 62. Europe Pravastatin Sales by Type (2018-2024) & (K Units)
Table 63. Europe Pravastatin Sales by Type (2024-2029) & (K Units)
Table 64. Europe Pravastatin Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Pravastatin Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Pravastatin Sales by Application (2018-2024) & (K Units)
Table 67. Europe Pravastatin Sales by Application (2024-2029) & (K Units)
Table 68. Europe Pravastatin Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Pravastatin Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Pravastatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Pravastatin Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Pravastatin Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Pravastatin Sales by Country (2018-2024) & (K Units)
Table 74. Europe Pravastatin Sales by Country (2024-2029) & (K Units)
Table 75. China Pravastatin Sales by Type (2018-2024) & (K Units)
Table 76. China Pravastatin Sales by Type (2024-2029) & (K Units)
Table 77. China Pravastatin Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Pravastatin Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Pravastatin Sales by Application (2018-2024) & (K Units)
Table 80. China Pravastatin Sales by Application (2024-2029) & (K Units)
Table 81. China Pravastatin Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Pravastatin Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Pravastatin Sales by Type (2018-2024) & (K Units)
Table 84. Asia Pravastatin Sales by Type (2024-2029) & (K Units)
Table 85. Asia Pravastatin Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Pravastatin Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Pravastatin Sales by Application (2018-2024) & (K Units)
Table 88. Asia Pravastatin Sales by Application (2024-2029) & (K Units)
Table 89. Asia Pravastatin Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Pravastatin Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Pravastatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Pravastatin Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Pravastatin Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Pravastatin Sales by Region (2018-2024) & (K Units)
Table 95. Asia Pravastatin Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Pravastatin Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Pravastatin Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Pravastatin Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Pravastatin Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Pravastatin Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Pravastatin Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Pravastatin Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Pravastatin Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pravastatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Pravastatin Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Pravastatin Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pravastatin Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Pravastatin Sales by Country (2024-2029) & (K Units)
Table 109. Bristol-Myers Squibb Company Information
Table 110. Bristol-Myers Squibb Description and Major Businesses
Table 111. Bristol-Myers Squibb Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Bristol-Myers Squibb Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bristol-Myers Squibb Recent Developments
Table 114. TEVA Company Information
Table 115. TEVA Description and Major Businesses
Table 116. TEVA Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. TEVA Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. TEVA Recent Developments
Table 119. SANDOZ Company Information
Table 120. SANDOZ Description and Major Businesses
Table 121. SANDOZ Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. SANDOZ Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. SANDOZ Recent Developments
Table 124. APOTEX Company Information
Table 125. APOTEX Description and Major Businesses
Table 126. APOTEX Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. APOTEX Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. APOTEX Recent Developments
Table 129. Dr. Reddy's Laboratories Company Information
Table 130. Dr. Reddy's Laboratories Description and Major Businesses
Table 131. Dr. Reddy's Laboratories Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Dr. Reddy's Laboratories Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Dr. Reddy's Laboratories Recent Developments
Table 134. Zydus Pharmaceuticals Company Information
Table 135. Zydus Pharmaceuticals Description and Major Businesses
Table 136. Zydus Pharmaceuticals Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Zydus Pharmaceuticals Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Zydus Pharmaceuticals Recent Developments
Table 139. Cipla Inc. Company Information
Table 140. Cipla Inc. Description and Major Businesses
Table 141. Cipla Inc. Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Cipla Inc. Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Cipla Inc. Recent Developments
Table 144. Lupin Pharmaceuticals Company Information
Table 145. Lupin Pharmaceuticals Description and Major Businesses
Table 146. Lupin Pharmaceuticals Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Lupin Pharmaceuticals Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Lupin Pharmaceuticals Recent Developments
Table 149. Glenmark Company Information
Table 150. Glenmark Description and Major Businesses
Table 151. Glenmark Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Glenmark Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Glenmark Recent Developments
Table 154. Mylan Company Information
Table 155. Mylan Description and Major Businesses
Table 156. Mylan Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Mylan Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Mylan Recent Developments
Table 159. Aurobindo Pharma Company Information
Table 160. Aurobindo Pharma Description and Major Businesses
Table 161. Aurobindo Pharma Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Aurobindo Pharma Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Aurobindo Pharma Recent Developments
Table 164. Accord Healthcare Company Information
Table 165. Accord Healthcare Description and Major Businesses
Table 166. Accord Healthcare Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Accord Healthcare Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Accord Healthcare Recent Developments
Table 169. Upsher-Smith Laboratories Company Information
Table 170. Upsher-Smith Laboratories Description and Major Businesses
Table 171. Upsher-Smith Laboratories Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Upsher-Smith Laboratories Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Upsher-Smith Laboratories Recent Developments
Table 174. Hisun Company Information
Table 175. Hisun Description and Major Businesses
Table 176. Hisun Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Hisun Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Hisun Recent Developments
Table 179. Jiangxi Boyaseehot Pharmaceutical Company Information
Table 180. Jiangxi Boyaseehot Pharmaceutical Description and Major Businesses
Table 181. Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Jiangxi Boyaseehot Pharmaceutical Recent Developments
Table 184. Shanghai Shyndec Pharmaceutical Company Information
Table 185. Shanghai Shyndec Pharmaceutical Description and Major Businesses
Table 186. Shanghai Shyndec Pharmaceutical Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Shanghai Shyndec Pharmaceutical Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Shanghai Shyndec Pharmaceutical Recent Developments
Table 189. Daiichi Sankyo Company Information
Table 190. Daiichi Sankyo Description and Major Businesses
Table 191. Daiichi Sankyo Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 192. Daiichi Sankyo Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Daiichi Sankyo Recent Developments
Table 194. North China Pharmaceutical Group Company Information
Table 195. North China Pharmaceutical Group Description and Major Businesses
Table 196. North China Pharmaceutical Group Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 197. North China Pharmaceutical Group Pravastatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. North China Pharmaceutical Group Recent Developments
Table 199. Key Raw Materials Lists
Table 200. Raw Materials Key Suppliers Lists
Table 201. Pravastatin Distributors List
Table 202. Pravastatin Customers List
Table 203. Pravastatin Market Trends
Table 204. Pravastatin Market Drivers
Table 205. Pravastatin Market Challenges
Table 206. Pravastatin Market Restraints
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Pravastatin Product Picture
Figure 2. Global Pravastatin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pravastatin Market Share by Type in 2022 & 2029
Figure 4. 10mg Tablet Product Picture
Figure 5. 20mg Tablet Product Picture
Figure 6. 40mg Tablet Product Picture
Figure 7. 80mg Tablet Product Picture
Figure 8. Global Pravastatin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Pravastatin Market Share by Application in 2022 & 2029
Figure 10. Adults
Figure 11. Children
Figure 12. Pravastatin Report Years Considered
Figure 13. Global Pravastatin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Pravastatin Revenue 2018-2029 (US$ Million)
Figure 15. Global Pravastatin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Pravastatin Revenue Market Share by Region (2018-2029)
Figure 17. Global Pravastatin Sales 2018-2029 ((K Units)
Figure 18. Global Pravastatin Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Pravastatin Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Pravastatin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Pravastatin Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Pravastatin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Pravastatin Sales YoY (2018-2029) & (K Units)
Figure 24. China Pravastatin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Pravastatin Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Pravastatin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Pravastatin Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Pravastatin Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Pravastatin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Pravastatin in the World: Market Share by Pravastatin Revenue in 2022
Figure 31. Global Pravastatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Pravastatin Sales Market Share by Type (2018-2029)
Figure 33. Global Pravastatin Revenue Market Share by Type (2018-2029)
Figure 34. Global Pravastatin Sales Market Share by Application (2018-2029)
Figure 35. Global Pravastatin Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Pravastatin Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Pravastatin Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Pravastatin Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Pravastatin Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Pravastatin Revenue Share by Country (2018-2029)
Figure 41. US & Canada Pravastatin Sales Share by Country (2018-2029)
Figure 42. U.S. Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Pravastatin Sales Market Share by Type (2018-2029)
Figure 45. Europe Pravastatin Revenue Market Share by Type (2018-2029)
Figure 46. Europe Pravastatin Sales Market Share by Application (2018-2029)
Figure 47. Europe Pravastatin Revenue Market Share by Application (2018-2029)
Figure 48. Europe Pravastatin Revenue Share by Country (2018-2029)
Figure 49. Europe Pravastatin Sales Share by Country (2018-2029)
Figure 50. Germany Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 51. France Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 55. China Pravastatin Sales Market Share by Type (2018-2029)
Figure 56. China Pravastatin Revenue Market Share by Type (2018-2029)
Figure 57. China Pravastatin Sales Market Share by Application (2018-2029)
Figure 58. China Pravastatin Revenue Market Share by Application (2018-2029)
Figure 59. Asia Pravastatin Sales Market Share by Type (2018-2029)
Figure 60. Asia Pravastatin Revenue Market Share by Type (2018-2029)
Figure 61. Asia Pravastatin Sales Market Share by Application (2018-2029)
Figure 62. Asia Pravastatin Revenue Market Share by Application (2018-2029)
Figure 63. Asia Pravastatin Revenue Share by Region (2018-2029)
Figure 64. Asia Pravastatin Sales Share by Region (2018-2029)
Figure 65. Japan Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 69. India Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Pravastatin Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Pravastatin Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Pravastatin Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Pravastatin Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Pravastatin Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Pravastatin Sales Share by Country (2018-2029)
Figure 76. Brazil Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Pravastatin Revenue (2018-2029) & (US$ Million)
Figure 81. Pravastatin Value Chain
Figure 82. Pravastatin Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed